Discover Orion's Sustainability Report 2023.

Stock exchange releases

• 8/14/2024 44,767 Orion Corporation A shares converted into B shares
• 8/8/2024 Orion Group Half-Year Financial Report January–June 2024
• 8/8/2024 Orion Corporation’s financial reporting and Annual General Meeting in 2025
• 7/17/2024 Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer meets primary endpoint

All releases 

Press releases

• 7/25/2024 Orion publishes Half-Year Financial Report for January–June 2024 and holds a webcast on 8 August 2024
• 6/3/2024 Orion is developing the Finnish life science industry in a unique collaboration project
• 4/11/2024 Orion publishes Interim Report for January–March 2024 and holds a webcast on 25 April 2024
• 3/22/2024 The change negotiations concerning Orion’s Kuopio plant have been concluded – the company has decided to continue to explore the outsourcing of production at the plant

All releases 